Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut bacterial surface receptors and structures on susceptible microbiota strains refers to the diverse array of molecular components—such as peptidoglycans, lipopolysaccharides, and surface proteins—that constitute the exterior of bacteria within the gastrointestinal tract (Lynch & Pedersen, 2016). These structures are essential for bacterial adhesion, nutrient transport, and interaction with the host immune system, serving as the primary interface between the microbiome and the human body (Belkaid & Hand, 2014). In clinical pharmacology, these components are the classical targets for antibiotics; for example, beta-lactams inhibit the synthesis of the peptidoglycan layer in susceptible strains. However, recent research has highlighted that many non-antibiotic drugs also inadvertently interact with these bacterial structures, leading to widespread dysbiosis and potential long-term health consequences (Maier et al., 2018). The selective targeting or preservation of specific microbial surface structures is a key area of research for developing precision medicines aimed at restoring gut homeostasis in diseases like inflammatory bowel disease and metabolic syndrome (Brown et al., 2013).
Inhibition of peptidoglycan cross-linking, disruption of the bacterial outer membrane, or competitive inhibition of mucosal adhesion.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut bacterial surface receptors and structures.